Get Started

ZOMDF

PINK Zomedica Corp
Nov 6, 2026 · 7:43 AM ET EOD Market Closed

$0.0933 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0933, $0.0056 below the day’s high of $0.0989

YTD change
-8.30%
vs 20-day SMA
+10.70%
vs 200-day SMA
-7.24%

Price ranges

Previous day
$0.0772 $0.0989
open $0.0865 close $0.0933
+$0.0068 (+7.86%)
Today
$0.0772 $0.0989
$0.0933
Past week
$0.0785 $0.0989
from $0.0830 now $0.0933
+$0.0103 (+12.41%)
Past month
$0.0750 $0.0989
from $0.0845 now $0.0933
+$0.0088 (+10.41%)
This year
$0.0700 $0.1580
from $0.1018 now $0.0933
-$0.0085 (-8.30%)

Price & Performance

+0.00 (+1.41%) / 6M

$0.0702$0.0862$0.1023$0.1183May 6Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 40.9% away from all-time highs of $0.1580
  • ZOMDF is down 8% since the beginning of the year
  • ZOMDF is up 15% over the past 12 months
  • ZOMDF is up 10% over the past 1 month
  • 0% of all ZOMDF investors are betting against ZOMDF

ZOMDF reads neutral: price sits above one of the two key moving averages, the 12-month move is +11.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0038
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $47.9M
Beta 1.04

Balance sheet & scale

IncomeN/A
Revenue$36.6M
Cash$44.1M
Debt$1.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Other Professional, Scientific, and Technical Services
Market cap $91.4M

Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. The firm offers products focusing on the unmet needs of clinical veterinarians. It operates through the following segments: Diagnostics, Therapeutic Devices, and Development Services. The Diagnostics segment offers TRUFORMA, VETGuardian and TRUVIEW products. The Therapeutic Devices segment consists of Assisi, PulseVet and VETIGEL products. The Development Services segment includes contract manufacturing and engineering services. The company was founded by Gerald L. Solensky on January 7, 2013 and is headquartered in Ann Arbor, MI.

Competitor comparison

TickerCompany PriceChange
IDXX IDEXX Laboratories, Inc. $670.71 -3.99%
IVPR Inspire Veterinary Partners, Inc. Class A $0.0001 +0.00%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.